Connection

Search Results to J. Mark Sloan, MD

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following properties of Sloan, J.

PropertyValue
Research Expertise & Professional Interests Factotum hematologist at Boston Medical Center and Associate Professor at Boston University School of Medicine. Program director for the hematology/oncology fellowship at Boston University.I see patients with a variety of benign and malignant blood disorders. I have particular research interests in AL Amyloidosis, HTLV-1 associated leukemia/lymphoma (ATLL), and Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN). Exceptional Care Without Exception.
Self-Described Keywords AL amyloidosis

One or more keywords matched the following items that are connected to Sloan, J.

Item TypeName
Concept Amyloidosis
Concept Serum Albumin
Concept Interferon-alpha
Concept Antineoplastic Agents, Alkylating
Academic Article Oral cyclic melphalan and dexamethasone for patients with AL amyloidosis.
Academic Article Macroglossia - not always AL amyloidosis.
Academic Article Outcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation: long-term results in a series of 421 patients.
Academic Article High-dose melphalan and autologous stem cell transplantation for AL amyloidosis: recent trends in treatment-related mortality and 1-year survival at a single institution.
Academic Article Bortezomib and high-dose melphalan conditioning for stem cell transplantation for AL amyloidosis: a pilot study.
Academic Article Multiple arterial and venous thromboembolic complications in AL amyloidosis and cardiac involvement: a case report and literature review.
Academic Article Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue with amyloid deposition: a clinicopathologic case series.
Academic Article Melphalan, lenalidomide and dexamethasone for the treatment of immunoglobulin light chain amyloidosis: results of a phase II trial.
Academic Article High-dose melphalan and stem cell transplantation for patients with AL amyloidosis: trends in treatment-related mortality over the past 17 years at a single referral center.
Academic Article Hospital admissions following outpatient administration of high-dose melphalan and autologous SCT for AL amyloidosis.
Academic Article Hematopoietic cell transplantation for plasmablastic lymphoma: a review.
Academic Article Simultaneous presentation of kappa-restricted chronic lymphocytic leukemia and lambda light chain AL amyloidosis.
Academic Article Induction Therapy with Bortezomib Followed by Bortezomib-High Dose Melphalan and Stem Cell Transplantation for Light Chain Amyloidosis: Results of a Prospective Clinical Trial.
Academic Article Plerixafor-augmented peripheral blood stem cell mobilization in AL amyloidosis with cardiac involvement: a case series.
Academic Article Risk factors for venous thromboembolism in immunoglobulin light chain amyloidosis.
Academic Article Safety and efficacy of high-dose melphalan and auto-SCT in patients with AL amyloidosis and cardiac involvement.
Academic Article Pomalidomide and dexamethasone in the treatment of AL amyloidosis: results of a phase 1 and 2 trial.
Academic Article The Effect of Bone Marrow Plasma Cell Burden on Survival in Patients with Light Chain Amyloidosis Undergoing High-Dose Melphalan and Autologous Stem Cell Transplantation.
Academic Article Clinical presentation and treatment responses in IgM-related AL amyloidosis.
Academic Article Effect of severe hypoalbuminemia on toxicity of high-dose melphalan and autologous stem cell transplantation in patients with AL amyloidosis.
Academic Article Surgical Management of Pulmonary Mucosa-Associated Lymphoid Tissue Lymphoma Associated With Light-Chain Deposition Disease.
Academic Article Long-term outcome of patients with AL amyloidosis treated with high-dose melphalan and stem cell transplantation: 20-year experience.
Academic Article Hematologic relapse in AL amyloidosis after high-dose melphalan and stem cell transplantation.
Academic Article High-Dose Melphalan and Stem Cell Transplantation in Patients on Dialysis Due to Immunoglobulin Light-Chain Amyloidosis and Monoclonal Immunoglobulin Deposition Disease.
Academic Article The incidence of atrial fibrillation among patients with AL amyloidosis undergoing high-dose melphalan and stem cell transplantation: experience at a single institution.
Academic Article Neuralgic amyotrophy following high-dose melphalan and autologous peripheral blood stem cell transplantation for AL amyloidosis.
Academic Article Adult T-cell Leukemia/Lymphoma: A Problem Abroad and at Home.
Academic Article Evaluation of a new continuous mononuclear cell collection procedure in a single transplant center cohort enriched for AL amyloidosis patients.
Academic Article High-dose melphalan and stem cell transplantation in AL amyloidosis with elevated cardiac biomarkers.
Academic Article Modified High-Dose Melphalan and Autologous Stem Cell Transplantation for Immunoglobulin Light Chain Amyloidosis.
Academic Article Bortezomib ocular toxicities: Outcomes with ketotifen.
Academic Article Long-term outcome of kidney transplantation in AL amyloidosis.
Academic Article Induction Therapy with Bortezomib and Dexamethasone and Conditioning with High-Dose Melphalan and Bortezomib Followed by Autologous Stem Cell Transplantation for Immunoglobulin Light Chain Amyloidosis: Long-Term Follow-Up Analysis.
Academic Article High-dose melphalan and autologous peripheral blood stem cell transplantation in patients with AL amyloidosis and cardiac defibrillators.
Academic Article Lessons in Long Term Survival from AL Amyloidosis.
Academic Article Prevalence and prognostic value of D-dimer elevation in patients with AL amyloidosis.
Academic Article Safety of autologous stem cell transplantation in patients with known Human T-cell Lymphotropic Viruses Type 1 and 2 infection: A case series of four patients.
Academic Article Systemic AL amyloidosis with an undetectable plasma cell dyscrasia: A zebra without stripes.
Academic Article Safety, tolerability, and response rates of daratumumab in relapsed AL amyloidosis: results of a phase 2 study.
Grant Idelalisib for IgM-Associated AL Amyloidosis
Academic Article Presence of t(11;14) in AL amyloidosis as a marker of response when treated with a bortezomib-based regimen.
Academic Article Organ responses after highdose melphalan and stemcell transplantation in AL amyloidosis.
Academic Article Comparing measures of hematologic response after high-dose melphalan and stem cell transplantation in AL amyloidosis.
Grant A Phase I Dose-Escalation Study of Carflizomib in Patients with Previously-Treated Systemic Light-Chain (AL) Amyloidosis

Highlights
Search Criteria
  • AL
  • amyloidosis